Segment Information (Tables)

6 Months Ended

Jun. 30, 2012



Three Months Ended June 30,	Agriculture¹			Electronics & Communications			Industrial Biosciences				Nutrition & Health			Performance Chemicals		Performance Coatings		Performance Materials		Safety & Protection		Pharm-aceuticals		Other				Total
2012
Segment sales	$	3,388		$	795		$	300			$	885		$	1,968	$	1,089	$	1,699	$	986	$	—	$	1			$	11,111
Less: Transfers	2			5			2				—			69		—		24		3		—		—				105
Net sales	3,386			790			298				885			1,899		1,089		1,675		983		—		1				11,006
PTOI	661		²	197		³	44				112			538		92		317		127		16		(206		)	⁴	1,898

2011
Segment sales	$	2,997		$	891		$	123			$	486		$	1,995	$	1,105	$	1,745	$	1,025	$	—	$	1			$	10,368
Less: Transfers	—			5			1				—			69		—		26		3		—		—				104
Net sales	2,997			886			122				486			1,926		1,105		1,719		1,022		—		1				10,264
PTOI	826			103			(7		)	⁵	5		⁵	503		73		254		143		80		(37		)		1,943



Six Months Ended June 30,	Agriculture¹			Electronics & Communications			Industrial Biosciences				Nutrition & Health			Performance Chemicals		Performance Coatings		Performance Materials		Safety & Protection		Pharm-aceuticals		Other				Total
2012
Segment sales	$	7,468		$	1,472		$	588			$	1,693		$	3,868	$	2,139	$	3,299	$	1,927	$	—	$	2			$	22,456
Less: Transfers	4			9			5				—			146		—		50		6		—		—				220
Net sales	7,464			1,463			583				1,693			3,722		2,139		3,249		1,921		—		2				22,236
PTOI	1,925		²	230		³	85				195			1,050		179		557		227		43		(266		)	⁴	4,225

2011
Segment sales	$	6,501		$	1,702		$	123			$	810		$	3,792	$	2,098	$	3,452	$	1,990	$	—	$	37			$	20,505
Less: Transfers	—			10			1				—			136		—		54		6		—		—				207
Net sales	6,501			1,692			122				810			3,656		2,098		3,398		1,984		—		37				20,298
PTOI	1,937			214			(7		)	⁵	30		⁵	897		138		542		288		130		(101		)		4,068


¹	As of June 30, 2012, Agriculture net assets were $8,221, an increase of $3,456 from $4,765 at December 31, 2011. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.


²	Included charges of $(265) and $(315) during the three and six months ended June 30, 2012, respectively, recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis^®. See Note 7 for additional information.


³	Included a $122 gain recorded in other income, net related to the sale of the company's interest in an equity method investment.


⁴	Included a $(137) charge recorded in cost of goods sold and other operating charges primarily related to the company's settlement of litigation with INVISTA. See Note 7 for additional information.


⁵	Included a $(50) charge for transaction related costs and the fair value step-up of inventories that were acquired as part of the Danisco acquisition in 2011, which impacted the segments as follows: Industrial Biosciences - $(17) and Nutrition & Health - $(33).

Reconciliation to Consolidated Income Statements



	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Total segment PTOI	$	1,898		$	1,943		$	4,225		$	4,068
Net exchange gains (losses), including affiliates	28			4			(52		)	(139		)
Corporate expenses and net interest	(289		)	(358		)	(595		)	(638		)
Income before income taxes	$	1,637		$	1,589		$	3,578		$	3,291

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations.

+ References+ Details

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details